abstract |
The invention relates to compounds of formula (I), in which X, Y, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP> and R<SUP>4</SUP> are defined as cited in claim 1. Said compounds are inhibitors of CHK1, CHK2 and SGK kinases and can be used to treat cancer and other diseases. |